United Parcel Service (UPS) is planning to test a service that will dispatch nurses to administer vaccines in a patient's home; survey results reveal that the majority of Americans think the government is spending too little on healthcare; and Biogen has halted 2 clinical trials testing an experimental treatment for Alzheimer disease.
Stepping its foot into the healthcare arena, UPS will test a service that dispatches nurses to vaccinate adults in their homes starting next year. According to Reuters, UPS will package and ship the vaccine from its healthcare complex to one of its stores, where a home health nurse will pick up the vaccine, bring it to the patient’s home, and administer it. While the postal service did not disclose which vaccines would be included in the service, Merck is looking into participating in the initiative.Data from the General Social Survey (GSS) indicate that Americans are not satisfied with the amount of money the government is spending on healthcare. Analyzing 2018 data, GSS and The Associated Press-NORC Center for Public Affairs Research staff found that 7 in 10 respondents of the survey said the government is spending too little on improving health in the country. Americans also want more spending on helping people deal with drug addiction, with 69% of respondents reporting that the government is spending too little on the issue.Biogen announced that it is nixing 2 late-stage clinical trials assessing aducanumab for Alzheimer disease, concluding that the experimental treatment was unlikely to benefit patients. However, scientists say the failure did reinforce the notion that removing amyloid plaques is too late for symptomatic patients. According to STAT News, the anti-amyloid compound is just 1 of hundreds that have failed to be effective in the disease, resulting in some questioning if a new approach is needed.
Urticaria Diagnosis Challenged by Overlapping Pruritic Skin Conditions
April 23rd 2025Urticaria is complicated to diagnose by its symptomatic overlap with other skin conditions and the frequent misclassification in literature of distinct pathologies like vasculitic urticaria and bullous pemphigus.
Read More
New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix
April 22nd 2025On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.
Listen
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
ACOs’ Focus on Rooting Out Fraud Aligns With CMS Vision Under Oz
April 23rd 2025Accountable care organizations (ACOs) are increasingly playing the role of data sleuths as they identify and report trends of anomalous billing in hopes of salvaging their shared savings. This mission dovetails with that of CMS, which under the new administration plans to prioritize rooting out fraud, waste, and abuse.
Read More